RA Capital Management - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 44 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,150,045
-29.8%
6,144,8810.0%0.26%
-26.8%
Q2 2023$18,741,887
+17.3%
6,144,8810.0%0.35%
-2.2%
Q1 2023$15,976,691
+81.6%
6,144,881
+43.2%
0.36%
+103.4%
Q4 2022$8,798,356
-54.5%
4,291,8810.0%0.18%
-56.9%
Q3 2022$19,356,000
+10.3%
4,291,8810.0%0.41%
-11.8%
Q2 2022$17,554,000
-7.0%
4,291,8810.0%0.47%
+13.6%
Q1 2022$18,884,000
-63.1%
4,291,8810.0%0.41%
-54.3%
Q4 2021$51,116,000
-30.6%
4,291,8810.0%0.90%
-11.8%
Q3 2021$73,649,000
-1.6%
4,291,8810.0%1.02%
-15.0%
Q2 2021$74,850,0004,291,8811.20%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
DC Funds, LP 589,102$10,274,00048.81%
MPM ASSET MANAGEMENT LLC 4,284,172$74,716,00013.89%
MPM BioImpact LLC 2,388,011$41,647,0006.84%
Soleus Capital Management, L.P. 563,396$9,826,0001.51%
RA Capital Management 4,291,881$74,850,0001.20%
SPHERA FUNDS MANAGEMENT LTD. 706,294$12,049,0000.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,552,787$44,521,0000.79%
Nicholas Investment Partners, LP 294,654$5,139,0000.32%
Avidity Partners Management LP 650,265$11,341,0000.31%
PFM Health Sciences, LP 400,000$6,976,0000.22%
View complete list of WEREWOLF THERAPEUTICS INC shareholders